Estela Bruxel to Attention Deficit Disorder with Hyperactivity
This is a "connection" page, showing publications Estela Bruxel has written about Attention Deficit Disorder with Hyperactivity.
Connection Strength
2.204
-
Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility. Mol Psychiatry. 2021 06; 26(6):2277-2285.
Score: 0.506
-
GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit/Hyperactivity Disorder. Am J Med Genet B Neuropsychiatr Genet. 2016 12; 171(8):1099-1104.
Score: 0.397
-
LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study. Genes Brain Behav. 2015 Jun; 14(5):419-27.
Score: 0.365
-
ADHD pharmacogenetics across the life cycle: New findings and perspectives. Am J Med Genet B Neuropsychiatr Genet. 2014 Jun; 165B(4):263-82.
Score: 0.339
-
Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate. Pharmacogenomics J. 2013 Oct; 13(5):476-80.
Score: 0.297
-
NOS1 and SNAP25 polymorphisms are associated with Attention-Deficit/Hyperactivity Disorder symptoms in adults but not in children. J Psychiatr Res. 2016 Apr; 75:75-81.
Score: 0.095
-
MAP1B and NOS1 genes are associated with working memory in youths with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2016 Jun; 266(4):359-66.
Score: 0.092
-
Lack of association between the GRM7 gene and attention deficit hyperactivity disorder. Psychiatr Genet. 2014 Dec; 24(6):281-2.
Score: 0.088
-
The role of protein intrinsic disorder in major psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2016 09; 171(6):848-60.
Score: 0.024